
Viking Therapeutics (VKTX) Earnings Dates & Reports
Viking Therapeutics (VKTX) Most Recent Earnings
Report DateOct 22, 2025
Period EndingQ3 2025
Est. EPS-$0.68
Actual EPS-$0.81
EarningsMiss
Viking Therapeutics (VKTX) Earnings
View the latest Viking Therapeutics (VKTX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Viking Therapeutics (VKTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Viking Therapeutics (VKTX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Viking Therapeutics (VKTX) Latest Earnings
The value each VKTX share was expected to gain vs. the value each share gained.
Viking Therapeutics (VKTX) reported its most recent earnings on Oct 22, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.81. This exceeded analysts' expectations of -$0.68 by 19.12%, marking a Miss.
For comparison, Viking Therapeutics reported EPS of -$0.22 in the same quarter last year.
The company is expected to announce its next earnings report on 02/04/2026, with analysts projecting an EPS of -$0.89.
Viking Therapeutics (VKTX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
|---|---|---|---|---|
Q4 2025Feb 4, 2026 | -$0.89 | Next earnings call Feb. 4, 2026 | ||
Q3 2025Oct 22, 2025 | -$0.68 | -$0.81 | +19.12% | |
Q2 2025Jul 23, 2025 | -$0.44 | -$0.58 | +31.82% | |
Q1 2025Apr 23, 2025 | -$0.31 | -$0.41 | +32.26% | |
Q4 2024Feb 5, 2025 | -$0.27 | -$0.32 | +18.52% | |
Viking Therapeutics (VKTX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Viking Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Oct 22, 2025 | — | — | — |
| Jul 23, 2025 | — | — | — |
| Apr 23, 2025 | — | — | — |
| Feb 5, 2025 | — | — | — |
Viking Therapeutics (VKTX) Earnings FAQs
Viking Therapeutics (VKTX) last reported earnings on Oct 22, 2025 for Q3 2025, posting an EPS of -$0.81, which Miss the estimate of -$0.68 by 19.12%.
For Q3 2025, Viking Therapeutics (VKTX) reported an EPS of -$0.81, missing analysts' estimate of -$0.68 by 19.12%.
For Q3 2025, Viking Therapeutics (VKTX) Miss expectations with an actual EPS of -$0.81 vs. an estimated EPS of -$0.68.
Following the last earnings report on Oct 22, 2025, Viking Therapeutics (VKTX)'s stock price moved — from — to —.
The next Viking Therapeutics (VKTX) earnings call is scheduled for Feb. 4, 2026, where executives will discuss financial results and outlook.